Volume 95 Issue 25 | p. 15 | Concentrates
Issue Date: June 19, 2017

Johnson Matthey teams with Intrexon

Department: Business
Keywords: outsourcing, pharmaceuticals, peptide, fermentation, active pharmaceutical ingredients

Johnson Matthey and and Intrexon, a Budapest-based biopharmaceutical firm, will jointly develop microbial strains for the production of peptide-based active pharmaceutical ingredients (APIs) via fermentation. Intrexon will contribute its proprietary microbial hosts and fermentation processes to the initial fermentation, isolation, and purification of APIs. Johnson Matthey will be responsible for scale-up, formulation, and commercialization of microbial strains.

To view the rest of this content, please log in with your ACS ID.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society